DRY EYE DIAGNOSTICS
AXIM is working with two specialized point-of-care (POC) lab testing systems designed specifically to assist eye-care physicians in detecting and quantifying a variety of biomarkers associated with external ocular disorders, such as Dry Eye
NeuCovix TM NEUTRALIZING ANTIBODY RAPID DIAGNOSTIC TEST
AXIM Biotechnologies has developed the first-in-class rapid
(10-minute) point-of-care test that measures the concentration of neutralizing antibodies to COVID-19. AXIM believes this rapid test will be useful in identifying the best convalescent plasma for treating patients fighting COVID-19 and for monitoring neutralizing antibodies elicited by COVID-19 vaccines.
Using proprietary polyclonal antibodies in collaboration with world-renowned research and academic centers, we have introduced a prototype diagnostic test that measures levels of QSOX1-L in blood and filed for patent protection.